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Mycobacterium tuberculosis is responsible for more human deaths every year than any 
other bacterium. In order to establish an infection and cause disease, M. tuberculosis requires the 
nutrient heme. Heme is essential for numerous processes within the cell but is also cytotoxic, so 
its synthesis, uptake, and utilization must be tightly regulated by the bacterium. Despite the 
important role of this nutrient, relatively little is known about the regulation of its abundance and 
bioavailability. To better understand heme dynamics in mycobacteria, a total heme fluorescence 
assay and genetically encoded exchange labile heme sensors were used to observe changes in the 
abundance and bioavailability of heme in Mycobacterium smegmatis under various conditions. 
These experiments demonstrate that heme abundance and bioavailability in mycobacteria can 
change in response to physiologically relevant stresses and environmental cues. 
Introduction 
 Mycobacterium tuberculosis (Mtb) is the etiological agent of tuberculosis and causes more 
deaths each year than any other pathogen. The World Health Organization estimates that one in 
four people are carriers of Mtb, with 10.0 million people developing tuberculosis and 1.4 million 
people dying from the disease in 2019 (World Health Organization, 2020). While most cases can 
be cured by antibiotics, drug resistant Mtb is a growing threat (World Health Organization, 2020). 
To facilitate the discovery of new treatments, a better understanding of the physiology of Mtb is 
required. This research project will investigate the dynamic nature of heme homeostasis in 
mycobacteria by observing changes in the concentration and bioavailability of heme in response 
to physiologically relevant conditions in vitro.  
 Tuberculosis is a respiratory disease which begins when a person inhales Mtb and the 
bacilli reach the alveoli. There, Mtb is engulfed by resident macrophages. If the macrophages are 
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successful in killing Mtb, the infection ends. If Mtb survives this initial encounter, it can invade 
the lung where the adaptive immune response will begin, a granuloma will form, and the bacteria 
will become dormant until the host’s immune system is weakened (Pai et al., 2016). Within 
macrophage phagosomes, Mtb faces the production of reactive oxygen species (ROS) and reactive 
nitrogen species (RNS) as well as phagosomal maturation. In order to survive these threats, Mtb 
must produce virulence factors that inhibit these processes or neutralize them as they occur 
(Forrellad et al., 2012).  
 Mtb uses heme for a wide range of functions including energy production, gas sensing, and 
the neutralization of the ROS and RNS produced by macrophages (Forrellad et al., 2012). During 
infection, Mtb must acquire heme or synthesize it from nutrients it scavenges from the host; 
however, the host has evolved mechanisms to deny Mtb iron, heme, and other nutrients. Therefore, 
a successful infection requires Mtb to evade these defenses (Choby & Skaar, 2016).  
 While heme is an essential nutrient for Mtb, it can also be toxic. If let loose in the cell, 
heme localizes to membranes where it can damage lipids, proteins, and nucleic acids which can 
lead to death (Choby & Skaar, 2016). The paradoxical role of heme in the biology of Mtb is why 
the cell must precisely control the abundance of heme, store it safely, and be able to quickly 
mobilize it in response to potentially deadly changes in its environment. Mtb has many ways of 
regulating the amount of heme in the cell including making new heme, destroying existing heme, 
scavenging heme from the host, and pumping heme out of the cell (Dailey et al., 2015, Nambu et 
al., 2013, Mitra et al., 2017). The fact that so many cellular components are dedicated to controlling 
cellular heme levels suggests that it is an important part of the physiology of Mtb. Because the 
systems involved in regulating heme are so important, they may be potential targets for new 
antibiotics. The heme biosynthetic enzyme, coproheme decarboxylase (ChdC), has been proposed 
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as a drug target because it is only found in Firmicutes and Actinobacteria (Dailey et al., 2010). 
Targeting this enzyme could fatally dysregulate heme homeostasis in Mtb while leaving human 
cells unharmed, reducing side effects.  
In order to better understand the role of heme in mycobacterial physiology it is necessary 
to directly observe heme within cells. Intracellular heme can either be inert, bound tightly to 
hemoproteins such as cytochromes, or exchange labile, bound loosely to proteins and easily 
transferred to other proteins to respond to the needs of the cell. To observe changes in the in these 
heme pools, two techniques have been developed which allow for the measurement of the total 
amount of intracellular heme by quantifying the fluorescence of the porphyrin component of each 
heme molecule and the exchange labile heme (ELH) within mycobacteria through the use of 
genetically encoded fluorescent heme sensors (Sassa, 1976, Hanna et al., 2016). Currently, the 
response of mycobacterial heme pools to challenges during infection has not been studied. To 
safely and efficiently gain insights into the biology of the pathogenic species Mtb, this work was 
performed on M. smegmatis (Msm), a nonpathogenic, rapid growing mycobacterium which is 
commonly used as a model organism for mycobacterial research. Using Msm allows for much 
faster experimentation without the risk of contracting tuberculosis. These experiments aim to 
observe the dynamic responses of the intracellular heme pools of Msm in response to some of the 
same stresses faced by Mtb in the host, which will shed light on the role of heme in mycobacterial 
pathogenesis. 
Literature Review 
The progression of each Mtb infection is governed by a series of complex interactions 
between the host and the invading microbe. The first obstacle which the tubercle bacillus must 
overcome is the innate immune system. Of particular interest in Mtb pathogenesis are the roles of 
4 
 
alveolar macrophages and nutritional immunity. Mtb infection begins when a bacillus is inhaled 
into an alveolus and subsequently phagocytosed by a resident macrophage (Pai et al., 2016). 
Within the macrophage, Mtb faces multiple threats including acidification, proteases, and the 
oxidative burst (Vandal et al., 2009). To protect itself from these attacks, Mtb produces proteins 
which inhibit the progression of these host defenses or neutralize them as they occur (Forrellad et 
al., 2012). In the latter case, KatG, the mycobacterial catalase-peroxidase, is required for survival 
and requires heme to function (Ng et al., 2004). While heme is understood to be an important 
component in mycobacterial physiology, the regulation of its synthesis, uptake, bioavailability, 
and utilization remains unknown. Through the use of genetically encoded ELH sensors and a total 
heme fluorescence assay, the extracellular conditions which alter heme homeostasis in 
mycobacteria may be better understood. 
In addition to direct attacks against invading pathogens, the host immune system also 
restricts access to essential nutrients such as iron in a process termed nutritional immunity (Hood 
& Skaar, 2012). It is most commonly used to refer to the sequestration of iron but has recently 
been expanded to include other transition metals like copper and zinc. In the human body, the vast 
majority of iron is incorporated into heme bound to hemoglobin inside erythrocytes, while the rest 
of the body’s iron is stored in ferritin, other iron storage proteins, or metalloenzymes (Hood & 
Skaar, 2012). The end result of this tightly controlled storage system is the withholding of iron and 
heme from Mtb. In order to establish a successful infection, Mtb must be able to take up enough 
iron and heme from the host to survive phagocytosis by alveolar macrophages (Skaar, 2010).  
While iron and heme are absolutely essential for a wide range of biochemical processes 
performed by Mtb, they are also potentially toxic. Heme is lipophilic and, if free within a cell, can 
localize to membranes where it can damage membrane proteins and lipids, potentially resulting in 
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cell death (Choby & Skaar, 2016). Heme can also be broken down to release the iron atom at its 
center. Through Fenton chemistry and the Haber-Weiss reaction, free iron will react with hydrogen 
peroxide to produce free radicals which can damage DNA, lipids, and proteins (Choby & Skaar, 
2016). 
These conflicting functions of heme present some interesting questions about the regulation 
of this cofactor during infection. If heme is necessary but toxic, how does the cell ensure that it is 
tightly controlled but readily available to respond to stress? For which stresses does Mtb have to 
synthesize new heme or repurpose existing heme? How is heme synthesis and mobilization 
regulated? How much heme is required to successfully establish infection? While much work has 
been performed to elucidate the mechanisms of heme synthesis and uptake, the regulation of these 
processes is poorly understood. The most comprehensive study of the systems biology of heme 
came from a TnSeq experiment with Mtb grown on different iron sources, including heme (Zhang 
et al., 2020). Many genes required for heme uptake and utilization were uncovered, and the zur 
gene was identified as a possible heme uptake regulator. However, the specific mechanisms for 
the control of heme synthesis and utilization were not identified. 
While the heme regulatory machinery is yet to be elucidated, advances in biochemical 
techniques for the precise measurement of heme within the cell have enabled researchers to 
observe dynamic changes in heme pools directly. The total quantity of heme within a cell can be 
split into two pools: exchange inert heme and ELH (Hanna et al., 2016). Exchange inert heme is 
tightly bound to proteins like cytochromes and is not readily transferred to other heme-binding 
proteins. ELH is more loosely bound to proteins and is readily exchanged between proteins (Hanna 
et al., 2016). This distinction is important when considering the dynamic mobilization of heme in 
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response to stress, in which Mtb must rapidly activate defense mechanisms which rely on heme, 
and therefore may scavenge ELH from its existing heme pool to produce those defenses.  
To observe changes in ELH, Reddi and colleagues developed ratiometric ELH sensors 
(Hanna et al., 2016). This genetically encoded engineered protein contains three domains. The first 
is the heme-binding domain of cytochrome b562 (Cyt b562), the second domain is enhanced green 
fluorescent protein (eGFP), and the third is Katushka 2 (mKATE2), a red fluorescent protein. 
When the Cyt b562 domain binds heme, eGFP fluorescence is quenched while mKATE2 
fluorescence remains relatively unaffected. Thus, the ratio of eGFP fluorescence to mKATE2 
fluorescence is inversely proportional to the concentration of ELH. The first-generation sensor, 
HS1, coordinates heme in the Cyt b562 domain between His and Met residues. These residues 
confer a sub-nanomolar Kd for ferrous heme, which is too tight to observe physiological changes 
in ELH. A second-generation sensor, HS1 M7A, was generated by replacing the heme-
coordinating Met7 residue with an Ala residue. This changed the ferrous heme Kd to 25 nM, which 
enables precise observations of changes in ELH. A third sensor, HS1 DM, was developed by 
mutating the heme-coordinating residues Met7 and His102 to Ala to ablate heme binding and is used 
to control for the effects of sensor production on mycobacterial physiology (Hanna et al., 2016). 
This project will leverage these ELH sensors and a total heme fluorescence assay to fill in 
gaps in the current understanding of mycobacterial heme homeostasis. Specifically, it will address 
the lack of specific knowledge of how heme is used by mycobacteria to respond to the fatal 
challenges posed by the innate immune system. This work will broadly enhance the understanding 
of the importance of mycobacterial pathogenesis and will provide a better physiological context 




Materials and Methods 
Bacterial Strains & Growth Conditions 
Mycobacterium smegmatis mc2155 were grown from laboratory stocks. Cultures were grown in 
Middlebrook 7H9 media (Difco) which was supplemented with 0.05% tween 80 and 10% ADS. 
ADS consists of water supplemented with 0.85% sodium chloride, 2% glucose, and 5% bovine 
serum albumin (Fraction V Gemini Biosciences). All growth was overnight at 37°C shaking at 
170-200 rpm. Growth was quantified by measuring the optical density at 600 nm (OD600) of liquid 
cultures diluted 1:20 in Tween 80.  
Exchange Labile Heme Assay 
The OD600 of cultures grown as described above was obtained before pelleting and washing twice 
with water. Cells were then resuspended at an OD600 of 10 in phosphate buffered saline (PBS). 200 
µL of this suspension was placed in a 96 well flat bottom Grenier Fluorotrac plate in technical 
duplicates. The fluorescence of WT Msm not expressing a sensor were measured and subtracted 
as background for the mKATE2 and eGFP channels. A Biotek Synergy MX plate reader was used 
to measure mKATE2 fluorescence with an excitation of 580 nm and an emission of 620 and eGFP 
fluorescence with an excitation of 480 nm and an emission of 510 nm. The mean of technical 
replicates was taken and used for the calculation of the eGFP/mKATE2 ratio for each sample. The 
means of the eGFP/mKATE2 ratios of the samples in each treatment group are reported in this 
study. 
Total Heme Assay 
The method for measuring total heme was described previously (Sassa, 1976). Samples were 
washed as described for ELH measurements above. 500 µL of each sample resuspended at an 
OD600 of 10 in PBS were pelleted, the supernatant was removed, and the pellets were frozen at -
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80°C. They were resuspended in 500 µL of 20 mM oxalic acid and then incubated overnight at 
4°C. 500 µL of 2M oxalic acid was added and mixed, and then each sample was divided into two 
500 µL aliquots. One aliquot was incubated at room temperature protected from light and would 
serve as a blank. The other was boiled at 100°C for 30 minutes protected from light. Both the blank 
and boiled samples were centrifuged at 21,100 x g for 2 minutes. For each blank and boiled sample, 
two technical replicates of 200 µL of supernatant were plated in a 96 well black flat bottom Grenier 
Fluorotrac plate. A Tecan Infinite 200 Pro plate reader was used to measure fluorescence with an 
excitation wavelength of 400 nm and emission at 662 nm. When heme is boiled in acid, the iron 
separates from the porphyrin ring. Protoporphyrin IX is fluorescent, and by subtracting the 
fluorescence of an unboiled aliquot of a sample from the fluorescence of a boiled aliquot of the 
same sample, the total amount of heme can be determined.  
Results 
Cultures of Msm in 7H9 media were supplemented with 25, 50, and 100 µM heme 
dissolved in dimethyl sulfoxide. Compared to untreated cells, there was no change in the growth, 
but there was a significant decrease in the ELH heme sensor ratio at 50 and 100 µM heme (Fig. 
1A & 1B). This indicates that there was an increase in ELH in response to greater amounts of 
environmental heme available to the cells. Another experiment showed that the total concentration 
of intracellular heme compared to untreated cultures increased when cells were supplemented with 
100 µM heme (Fig. 1C). To see if Msm could grow using only exogenous heme, null mutants of 
the terminal heme biosynthetic enzyme coproheme decarboxylase were grown with and without a 
25 µM heme supplement (Fig. 2). The heme starved mutant suffered an approximately five-fold 
decrease in growth compared to wild type. The supplemented mutant cultures were rescued to a 
level slightly below the wild type.  
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 Cultures were treated with 5 µg/mL 5-aminolevulinic acid (ALA), a heme synthesis 
precursor common to humans and mycobacteria. ALA supplementation did not alter growth 
compared to untreated cells but did increase total heme and ELH (Fig. 3). After treatment in 7H9 
with 150 µM iron, neither the growth, total heme, nor ELH was altered compared to untreated 
cultures (Fig. 4). Bathophenanthrolinedisolfonic acid (BPS) is an iron chelator. This means that it 
can bind iron in the culture media and has the potential to prevent cells from scavenging the 
element. When cultures were treated with 75 and 150 µM BPS dissolved in phosphate buffered 
saline, there was no significant change in growth or ELH compared to untreated cells (Fig. 5). 
However, there is a slight but not statistically significant trend towards increased ELH, and higher 
concentrations of BPS may induce significant increases in ELH. Interestingly, total heme increased 
in response to increasing amounts of BPS. 
 Exposing mycobacteria to acidic conditions is a key component of the immune response to 
infection (Ehrt and Schnappinger, 2009). In vivo, the pH of bacteria containing phagolysosomes 
can reach as low as 4.5, but previous studies suggest that when 7H9 media is acidified to that level, 
mycobacteria may encounter toxicity that is not physiologically relevant (Vandal et al., 2008). In 
order to observe changes in mycobacterial heme pools in response to acidification while avoiding 
this type of toxicity, the pH of the 7H9 media was lowered from the standard 6.75 to a slightly 
more acidic pH of 6.03. While this is a relatively small change in pH, it was enough to inhibit 









Figure 1. Environmental heme availability increases total and exchange labile heme.  OD600 (A), 
M7A sensor ratio (B), and total heme fluorescence (C) of wild type Msm with 0, 25, 50, or 100 
µM heme. Bars show the mean of two replicates. Error bars show one standard error from the 
mean. Data were analyzed with one-way ANOVA and Tukey-Kramer HSD post-hoc test. p > 0.05 







Figure 2. Msm can scavenge heme. Bars show the mean OD600 of three replicates of wild type 
(WT), ΔchdC, and ΔchdC with 25 µM heme. Error bars show one standard error from the mean. 
Data were analyzed with one-way ANOVA and Tukey-Kramer HSD post-hoc test. n.s. indicates 









Figure 3. ALA supplementation increases heme abundance and bioavailability. OD600 (A), M7A 
sensor ratio (B), and total heme fluorescence (C) of wild type Msm with 0 or 5 µg/mL ALA. Bars 
represent the mean of three replicates. Error bars show one standard error from the mean. Data 











Figure 4. Heme abundance and bioavailability are unresponsive to iron supplementation in rich 
media. OD600 (A), M7A sensor ratio (B), and total heme fluorescence (C) of wild type Msm with 
0 or 150 µM iron. Bars represent the mean of three replicates. Error bars show one standard error 








Figure 5. Iron depletion increases intracellular heme.  OD600 (A), M7A sensor ratio (B), and total 
heme fluorescence (C) of wild type Msm with 0, 75, or 150 µM of the iron chelator BPS. Bars 
show the mean of three replicates. Error bars show one standard error from the mean. Data were 








Figure 6. Acidification inhibits growth, increases total heme, and decreases heme bioavailability. 
OD600 (A), M7A sensor ratio (B), and total heme fluorescence (C) of wild type Msm cultured in 
untreated (pH = 6.75) and acidified (pH = 6.03). Bars represent the mean of three replicates. Error 










Heme is required for mycobacterial growth and pathogenesis (Forrellad et al., 2012). It 
serves as a cofactor for numerous essential enzymes and is an important source of nutritional iron 
(Jones & Niederweis, 2011). Heme’s importance is further evidenced by the fact that mycobacteria 
evolved at least two heme uptake mechanisms and a de novo heme synthesis pathway (Mitra et al., 
2019 & Dailey et al., 2015). Despite the essential role of heme and the wide range of processes it 
is involved in, whether the abundance and bioavailability of mycobacterial heme are responsive to 
environmental conditions is unknown. To better understand the dynamics of heme pools in 
mycobacteria, ELH sensors and a total heme fluorescence assay were used to observe changes in 
heme quantities in response to pathologically relevant environmental conditions. Treatment with 
heme, ALA, and BPS, as well as acidification increased the total quantity of heme in Msm. Heme 
and ALA treatment increased ELH while acidification decreased it. Iron treatment had no effect 
on heme pools. Of all the treatments, only acidification altered growth, decreasing it by about one 
third compared to control. This work demonstrates that heme pools within Msm are dynamic and 
are altered in response to pathologically relevant environmental conditions modeled in vitro.  
The metallobiology of bacteria is a wide-ranging field with implications for microbial cell 
biology, ecology, and pathogenesis. Building an understanding of bacterial metallostasis is an 
important endeavor that is not limited to any one microbe. It must be noted that while the aim of 
these experiments was to gain insights into mycobacterial biology, one must be cautious when 
generalizing findings from a model organism. Msm and Mtb are both mycobacteria, but they are 
quite different. Msm is a soil microbe that rarely causes infections in humans, and the vast majority 
of those infections are skin and soft tissue infections that result from the contamination of wounds 
(Pierre-Audigier et al., 1997). In contrast, Mtb is an obligate human pathogen which commonly 
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causes severe disease (Pai et al., 2016). The different lifestyles of these microbes expose them to 
very different evolutionary pressures. 
As mentioned earlier, one of the greatest challenges in becoming a successful pathogen is 
evolving mechanisms to overcome nutritional immunity (Skaar, 2010). Because the vast majority 
of iron in the host is bound in heme, one way to scavenge a sufficient amount of iron would be to 
develop a heme uptake pathway. Recent work has uncovered two independent heme uptake 
systems in Mtb (Mitra et al., 2019). One involves outer membrane associated PPE proteins that 
likely pass heme to DppA, which in turn transfers heme to the DppBCD transporter to bring it 
through the inner membrane. The factors involved in the second pathway are unknown, but it is 
dependent on heme bound to the host protein albumin.  
While Msm and Mtb use the same heme synthesis pathway, the characterized heme uptake 
pathway of Mtb is not found in Msm. According to the comprehensive mycobacterial genome 
browser MycoBrowser, no orthologues of the seven genes coding for the known components of 
the Mtb heme uptake system can be found in the Msm genome (Kapopoulou et al., 2011). 
However, the uncharacterized Mtb heme uptake pathway allows for the use of albumin bound 
heme, which is in 7H9 media and may be the pathway used by Msm. The finding that the total 
heme and ELH increase after heme treatment and that heme auxotrophs can be rescued by heme 
supplementation is consistent with the idea that exogenous heme is not simply a nutritional source 
of iron but can supplement endogenous heme pools. Heme that enters the cell may be directly 
transferred to a hemoprotein to perform heme dependent processes such as the neutralization of 
hydrogen peroxide by KatG or it can be broken down into mycobilin and iron, which can be used 
for iron dependent activities or recycled in de novo heme synthesis. When Msm synthesizes new 
18 
 
heme, at least some of it enters the ELH pool, as evidenced by the fact that ALA treatment 
increases total and ELH.  
Comparative experiments have demonstrated that there is much variation in mycobacterial 
nutrient uptake systems. It is believed that as Mtb became a more specialized pathogen, its genome 
was simplified. Mtb has approximately 2.5 million fewer base pairs in its genome than Msm (Salah 
et al., 2009). One analysis showed that Msm can express twenty-eight putative carbohydrate 
transporters whereas Mtb only has five (Titgemeyer et al., 2007). Msm also produces a class of 
siderophores that are not produced by Mtb. Siderophores are small molecules that tightly bind 
ferric iron and are used to scavenge the nutrient from the environment. Msm and Mtb make 
carboxymycobactins and mycobactins and Msm can also make exochelins (Sritharan, 2016). 
Carboxymycobactins are water soluble siderophores which are secreted to bind iron that is in close 
proximity to the bacterium. In contrast, mycobactins are water insoluble and localize to the waxy 
outer membrane of the cell. It is hypothesized that the soluble carboxymycobactins transfer iron 
to mycobactins in order to bring the nutrient into the cell. Exochelins are mycobacterial 
siderophores which are only produced by the nonpathogenic members of the genus such as Msm 
and are thought to perform similarly to carboxymycobactins. Like heme, iron is potentially 
cytotoxic, and its cellular abundance and bioavailability are also tightly regulated. In Mtb, it has 
been shown that siderophore biosynthesis is downregulated by iron availability and upregulated 
during iron depletion (Pandey, et al., 2014). 
One of the most interesting results from these experiments was that iron supplementation 
in rich media does not affect growth, ELH, or total heme. This is in contrast to supplementation 
with heme, so it may be that heme uptake regulation is less sensitive to iron availability than the 
factors that regulate iron uptake. Unlike mycobacterial siderophores which bind ferric, BPS binds 
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ferrous iron. This means that in the BPS experiment, the siderophores and BPS were not directly 
competing for iron. However, by decreasing the total amount of free iron, BPS did likely decrease 
the ferric iron available to siderophores. Despite decreasing the availability of iron, which is 
required for heme synthesis, BPS at and above 75 µM increased the total intracellular 
concentration of heme. Oddly, BPS treatment was the only treatment that increased the total 
abundance of heme without changing the amount of ELH. One explanation for this could be that 
when iron and heme are abundant, more heme is transiently bound to hemoproteins and is not 
being used, but when iron is limited, the cell must partition its heme to only the most essential 
heme dependent processes, preventing the ELH pool from growing. Many bacteria use iron 
depletion as a signal that they have entered the host, so the increase in total heme may be part of 
the cell’s preparation to survive challenges from the immune system (Skaar, 2010). 
One of the main differences between Msm and Mtb is the ability to survive engulfment by 
phagocytes. Despite some similarities, Msm is much worse at persisting in phagocytes (Sharbati-
Tehrani et al., 2005). When mycobacteria are phagocytosed by eukaryotes, they are engulfed in a 
compartment called a phagosome where they can usually survive. However, after phagosome 
maturation, a process in which the phagosome fuses with the lysosome, the compartmental 
environment becomes much more hostile. Specifically in human macrophages, mycobacteria face 
oxidative and nitrosative stress, nutrient limitation, hydrolases, and acidification (Forrellad et al., 
2013). Some of the factors used to defend against these threats are common to both species like 
KatG and an iron containing superoxide dismutase SodA (Kapopoulou et al., 2011). The pH of the 




When the pH of 7H9 media was reduced slightly from 6.75 to 6.05, total heme in Msm 
increased while the ELH pool became smaller (Fig. 7). A crucial component of mycobacterial acid 
persistence is the integrity of the cell envelope. In screens of genes important for acid resistance, 
many factors involved in cell envelope maintenance have been identified (Vandal et al., 2009). 
Additionally, the increased permeability of the Msm cell envelope was identified as a limiting 
factor in its ability to tolerate phagocytosis (Sharbati-Tehrani et al., 2005). Heme is a lipophilic 
compound and if free will localize to the cell envelope where it is capable of damaging the cell 
membrane and membrane proteins (Choby & Skaar, 2016). The decrease in the ELH pool that 
occurs during growth in acidic conditions may be due to cells buffering heme with more tightly 
binding hemoproteins in order to avoid membrane damage that may reduce acid tolerance. 
Further research is needed to understand the full range of conditions for which heme and 
its dynamic mobilization occur in mycobacteria and the extent to which heme homeostasis is 
involved in mycobacterial growth and pathogenesis. It is also important to gain an understanding 
of the factors involved in regulating heme homeostasis in mycobacteria. Additionally, future work 
should address the partitioning of heme within the cell. Acidification and iron deprivation 
increased total heme without growing the ELH pool, indicating that under certain conditions, 
specific heme dependent processes are prioritized over other potential destinations for newly 
synthesized or scavenged heme. With a more complete understanding of mycobacterial heme 
homeostasis, new drugs disrupting heme synthesis, uptake, and utilization could be used to prevent 
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